LifeStance Health Group, Inc. LFST NASDAQ

LifeStance Health Group, Inc. (LFST) has shown strong revenue growth over the past 3 years, expanding from $860M to $1.4B (average +18.4%/yr). Net income reached $10M, reflecting exceptional earnings expansion at +66.5%/yr on average. The net profit margin is 0.7%, which is thin. the company was profitable in 1 out of the last 4 years tracked. The gross margin is 28.5% (low), with a +0.9pp trend over the period. With a $3B market cap and MOAT composite score of 49/100, the company has a moderate competitive position.

Criteria proven by this page:

• GROWTH (90/100, Pass) — proving strong growth momentum
• PAST (25/100, Fail) — the company has frequently reported losses. Looking at the full 7-year history, the company was profitable in 2 of 7 years — a mixed long-term record
• INCOME (30/100, Partial) — the company is profitable but margin is below 15%
• MOAT (49/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 59/100 with 2/7 criteria passed.